Priya S. Kishnani

22.6k total citations
456 papers, 12.8k citations indexed

About

Priya S. Kishnani is a scholar working on Physiology, Rheumatology and Molecular Biology. According to data from OpenAlex, Priya S. Kishnani has authored 456 papers receiving a total of 12.8k indexed citations (citations by other indexed papers that have themselves been cited), including 300 papers in Physiology, 257 papers in Rheumatology and 91 papers in Molecular Biology. Recurrent topics in Priya S. Kishnani's work include Lysosomal Storage Disorders Research (293 papers), Glycogen Storage Diseases and Myoclonus (241 papers) and Carbohydrate Chemistry and Synthesis (88 papers). Priya S. Kishnani is often cited by papers focused on Lysosomal Storage Disorders Research (293 papers), Glycogen Storage Diseases and Myoclonus (241 papers) and Carbohydrate Chemistry and Synthesis (88 papers). Priya S. Kishnani collaborates with scholars based in United States, Germany and United Kingdom. Priya S. Kishnani's co-authors include Deeksha Bali, Laura E. Case, Dwight D. Koeberl, Stephanie Austin, Sarah P. Young, Suhrad G. Banugaria, Deyanira Corzo, Hanna Mandel, Harrison N. Jones and Baodong Sun and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Priya S. Kishnani

439 papers receiving 12.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Priya S. Kishnani United States	56	7.6k	6.4k	2.6k	2.4k	2.2k	456	12.8k
Roberto Giugliani Brazil	60	10.5k 1.4×	3.4k 0.5×	3.4k 1.3×	1.9k 0.8×	4.8k 2.2×	641	15.0k
Ans T. van der Ploeg Netherlands	50	6.5k 0.9×	4.3k 0.7×	1.8k 0.7×	1.6k 0.7×	1.5k 0.7×	228	8.2k
Michael Beck Germany	59	10.9k 1.4×	3.7k 0.6×	1.6k 0.6×	2.4k 1.0×	5.2k 2.4×	213	12.2k
Frits A. Wijburg Netherlands	60	6.1k 0.8×	1.6k 0.2×	4.1k 1.5×	1.2k 0.5×	2.3k 1.0×	282	11.5k
Joseph Muenzer United States	40	5.2k 0.7×	1.8k 0.3×	1.4k 0.5×	805 0.3×	2.3k 1.0×	128	6.9k
Atul Mehta United Kingdom	57	7.2k 1.0×	1.6k 0.3×	2.6k 1.0×	1.9k 0.8×	3.3k 1.5×	237	11.1k
Gregory M. Pastores United States	50	7.5k 1.0×	1.4k 0.2×	2.2k 0.8×	2.3k 1.0×	3.1k 1.4×	204	8.8k
Generoso Andria Italy	46	2.3k 0.3×	2.6k 0.4×	2.9k 1.1×	811 0.3×	1.1k 0.5×	215	8.5k
Rossella Parini Italy	38	3.1k 0.4×	1.6k 0.3×	1.5k 0.6×	750 0.3×	1.3k 0.6×	179	5.1k
Yasuyuki Suzuki Japan	50	3.4k 0.5×	956 0.2×	3.8k 1.5×	747 0.3×	1.4k 0.6×	223	7.3k

Countries citing papers authored by Priya S. Kishnani

Since Specialization

Citations

This map shows the geographic impact of Priya S. Kishnani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Priya S. Kishnani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Priya S. Kishnani more than expected).

Fields of papers citing papers by Priya S. Kishnani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Priya S. Kishnani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Priya S. Kishnani. The network helps show where Priya S. Kishnani may publish in the future.

Co-authorship network of co-authors of Priya S. Kishnani

This figure shows the co-authorship network connecting the top 25 collaborators of Priya S. Kishnani. A scholar is included among the top collaborators of Priya S. Kishnani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Priya S. Kishnani. Priya S. Kishnani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Grabowski, Gregory A., Priya S. Kishnani, Roy N. Alcalay, et al.. (2025). Challenges in Gaucher disease: Perspectives from an expert panel. Molecular Genetics and Metabolism. 145(1). 109074–109074. 3 indexed citations

Spiridigliozzi, Gail A., et al.. (2025). Exploring the use of the National Institutes of Health Toolbox Cognition Battery with children and adolescents with Pompe disease: Preliminary findings. Molecular Genetics and Metabolism. 144(3). 109043–109043.

Kishnani, Priya S., Lothar Seefried, Kathryn Dahir, et al.. (2025). Disease burden by ALPL variant number in patients with non-life-threatening hypophosphatasia in the Global HPP Registry. Journal of Medical Genetics. 62(4). 249–257. 4 indexed citations

Rehder, Catherine, Gerald Webersinke, Cheryl R. Greenberg, et al.. (2025). Biochemical phenotype of hypophosphatasia in asymptomatic individuals carrying ALPL variants. Journal of Bone and Mineral Research. 41(3). 259–269. 1 indexed citations

Kishnani, Priya S., Lothar Seefried, Kathryn Dahir, et al.. (2024). New insights into the landscape of ALPL gene variants in patients with hypophosphatasia from the Global HPP Registry. American Journal of Medical Genetics Part A. 194(11). e63781–e63781. 7 indexed citations

Kenney‐Jung, Daniel, et al.. (2024). Gaucher disease type 3c: Expanding the clinical spectrum of an ultra‐rare disease. JIMD Reports. 65(5). 313–322. 1 indexed citations

Soler‐Alfonso, Claudia, Ariana L. Smith, Deeksha Bali, et al.. (2023). Diagnosis and management of glycogen storage disease type IV, including adult polyglucosan body disease: A clinical practice resource. Molecular Genetics and Metabolism. 138(3). 107525–107525. 21 indexed citations

Neel, Amy T., et al.. (2023). Speech Disorders in Children With Pompe Disease: Articulation, Resonance, and Voice Measures. American Journal of Speech-Language Pathology. 32(4). 1501–1516. 1 indexed citations

Kenney‐Jung, Daniel, Gail A. Spiridigliozzi, Walter F. Wiggins, et al.. (2023). Severe CNS involvement in a subset of long-term treated children with infantile-onset Pompe disease. Molecular Genetics and Metabolism. 141(2). 108119–108119. 12 indexed citations

10.

Koch, Rebecca E., Claudia Soler‐Alfonso, Bridget Kiely, et al.. (2023). O18: A path forward for patients with glycogen branching enzyme deficiency: Consensus on diagnosing and managing glycogen storage disease type IV*. SHILAP Revista de lepidopterología. 1(1). 100114–100114. 1 indexed citations

11.

Kishnani, Priya S., David Kronn, Shugo Suwazono, et al.. (2023). Higher dose alglucosidase alfa is associated with improved overall survival in infantile-onset Pompe disease (IOPD): data from the Pompe Registry. Orphanet Journal of Rare Diseases. 18(1). 381–381. 6 indexed citations

12.

Lianoglou, Billie R., Sarah P. Young, Deeksha Bali, et al.. (2023). Intrauterine enzyme replacement therapies for lysosomal storage disorders: Current developments and promising future prospects. Prenatal Diagnosis. 43(13). 1638–1649. 12 indexed citations

13.

Santoro, Stephanie L., Nicole Baumer, Catherine Franklin, et al.. (2022). Unexplained regression in Down syndrome: Management of 51 patients in an international patient database. American Journal of Medical Genetics Part A. 188(10). 3049–3062. 21 indexed citations

14.

Jones, Harrison N., et al.. (2020). Adenotonsillectomy should be avoided whenever possible in infantile-onset Pompe disease. Molecular Genetics and Metabolism Reports. 23. 100574–100574. 2 indexed citations

15.

McNamara, Erin R., Jennifer A. Sullivan, Shashi Nagaraj, John S. Wiener, & Priya S. Kishnani. (2014). Neurogenic Bladder Dysfunction Presenting as Urinary Retention in Neuronopathic Gaucher Disease. JIMD Reports. 15. 67–70. 3 indexed citations

16.

Yi, Haiqing, Elizabeth D. Brooks, Beth L. Thurberg, et al.. (2014). Correction of glycogen storage disease type III with rapamycin in a canine model. Journal of Molecular Medicine. 92(6). 641–650. 30 indexed citations

17.

Case, Laura E., et al.. (2012). Infantile Pompe disease on ERT—Update on clinical presentation, musculoskeletal management, and exercise considerations. American Journal of Medical Genetics Part C Seminars in Medical Genetics. 160C(1). 69–79. 57 indexed citations

18.

Koeberl, Dwight D., Songtao Li, Jian Dai, et al.. (2011). β2 Agonists enhance the efficacy of simultaneous enzyme replacement therapy in murine Pompe disease. Molecular Genetics and Metabolism. 105(2). 221–227. 40 indexed citations

19.

Heller, James H., Gail A. Spiridigliozzi, Blythe G. Crissman, et al.. (2006). Safety and Efficacy of Rivastigmine in Adolescents with Down Syndrome: A Preliminary 20-Week, Open-Label Study. Journal of Child and Adolescent Psychopharmacology. 16(6). 755–765. 33 indexed citations

20.

Kishnani, Priya S., et al.. (1994). Identification of mutations in Type IV glycogen storage disease. The American Journal of Human Genetics. 55. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact